BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30044532)

  • 1. The non-coding RNA OTUB1-isoform2 promotes ovarian tumour progression and predicts poor prognosis.
    Wang S; Ning Y; Wei P; Cai D; Lu L; Li J; Wang Y
    J Cell Mol Med; 2018 Oct; 22(10):4794-4806. PubMed ID: 30044532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of the Non-Coding RNA OTUB1-isoform 2 Contributes to Gastric Cancer Cell Proliferation and Invasion and Predicts Poor Gastric Cancer Prognosis.
    Wang YQ; Zhang QY; Weng WW; Wu Y; Yang YS; Shen C; Chen XC; Wang L; Liu KJ; Xu MD; Sheng WQ
    Int J Biol Sci; 2016; 12(5):545-57. PubMed ID: 27019636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of long non-coding RNA LOC400891 promotes tumor progression and poor prognosis in prostate cancer.
    Wang J; Cheng G; Li X; Pan Y; Qin C; Yang H; Hua L; Wang Z
    Tumour Biol; 2016 Jul; 37(7):9603-13. PubMed ID: 26797783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of OTUB1 in hepatocellular carcinoma and its effects on HCC cell migration and invasion.
    Ni Q; Chen J; Li X; Xu X; Zhang N; Zhou A; Zhou B; Lu Q; Chen Z
    Acta Biochim Biophys Sin (Shanghai); 2017 Aug; 49(8):680-688. PubMed ID: 28575188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OTUB1 promotes metastasis and serves as a marker of poor prognosis in colorectal cancer.
    Zhou Y; Wu J; Fu X; Du W; Zhou L; Meng X; Yu H; Lin J; Ye W; Liu J; Peng H; Liu RY; Pan C; Huang W
    Mol Cancer; 2014 Nov; 13():258. PubMed ID: 25431208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of long intergenic noncoding RNA 01296 in ovarian cancer impacts invasion, apoptosis and cell cycle distribution via regulating EMT.
    Xu H; Zheng JF; Hou CZ; Li Y; Liu PS
    Cell Signal; 2019 Oct; 62():109341. PubMed ID: 31176022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SALL4 is a marker of poor prognosis in serous ovarian carcinoma promoting invasion and metastasis.
    Yang M; Xie X; Ding Y
    Oncol Rep; 2016 Mar; 35(3):1796-806. PubMed ID: 26750614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of SNHG3 expression associated with poor prognosis and enhances malignant progression of ovarian cancer.
    Hong L; Chen W; Wu D; Wang Y
    Cancer Biomark; 2018; 22(3):367-374. PubMed ID: 29758922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA NRON is downregulated in HCC and suppresses tumour cell proliferation and metastasis.
    Yao Z; Xiong Z; Li R; Liang H; Jia C; Deng M
    Biomed Pharmacother; 2018 Aug; 104():102-109. PubMed ID: 29772429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis.
    Huang S; Qing C; Huang Z; Zhu Y
    Diagn Pathol; 2016 Jun; 11(1):49. PubMed ID: 27283598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OTUB1-catalyzed deubiquitination of FOXM1 facilitates tumor progression and predicts a poor prognosis in ovarian cancer.
    Wang Y; Zhou X; Xu M; Weng W; Zhang Q; Yang Y; Wei P; Du X
    Oncotarget; 2016 Jun; 7(24):36681-36697. PubMed ID: 27167337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of SENP3/SMT3IP1 promotes epithelial ovarian cancer progression and forecasts poor prognosis.
    Cheng J; Su M; Jin Y; Xi Q; Deng Y; Chen J; Wang W; Chen Y; Chen L; Shi N; Mao G
    Tumour Biol; 2017 Mar; 39(3):1010428317694543. PubMed ID: 28351334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA ANRIL predicts poor prognosis and promotes invasion/metastasis in serous ovarian cancer.
    Qiu JJ; Lin YY; Ding JX; Feng WW; Jin HY; Hua KQ
    Int J Oncol; 2015; 46(6):2497-505. PubMed ID: 25845387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo.
    Zeng S; Liu S; Feng J; Gao J; Xue F
    Cancer Biomark; 2019; 24(4):421-428. PubMed ID: 30909184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Non-coding RNA
    Yim GW; Kim HJ; Kim LK; Kim SW; Kim S; Nam EJ; Kim YT
    Cancer Res Treat; 2017 Jul; 49(3):656-668. PubMed ID: 27737536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA TC0101441 induces epithelial-mesenchymal transition in epithelial ovarian cancer metastasis by downregulating KiSS1.
    Qiu JJ; Lin XJ; Tang XY; Zheng TT; Zhang XY; Hua KQ
    Int J Cancer; 2020 May; 146(9):2588-2598. PubMed ID: 31577838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of long noncoding RNA TUSC7 promoted cell growth, invasion and migration through sponging with miR-616-5p/GSK3β pathway in ovarian cancer.
    Zhu LM; Li N
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7253-7265. PubMed ID: 32706063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HOXD-AS1 is a predictor of clinical progression and functions as an oncogenic lncRNAs in papillary thyroid cancer.
    Xu K; Feng Y
    J Cell Biochem; 2019 Apr; 120(4):5326-5332. PubMed ID: 30317670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway.
    Li J; Feng L; Tian C; Tang YL; Tang Y; Hu FQ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8135-8144. PubMed ID: 30556851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression of long non-coding RNA GAS5 promotes cell proliferation, migration and invasion, and indicates a poor prognosis in ovarian cancer.
    Li J; Huang H; Li Y; Li L; Hou W; You Z
    Oncol Rep; 2016 Dec; 36(6):3241-3250. PubMed ID: 27779700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.